We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Breast Cancer During Pregnancy (BRCAPRE)

This study is currently recruiting participants.
Verified March 2014 by Hospital Universitari Vall d'Hebron Research Institute
Sponsor:
ClinicalTrials.gov Identifier:
NCT02102282
First Posted: April 2, 2014
Last Update Posted: April 2, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Hospital Universitari Vall d'Hebron Research Institute
March 29, 2014
April 2, 2014
April 2, 2014
October 2012
December 2022   (Final data collection date for primary outcome measure)
Perinatal results [ Time Frame: Delivery ]
Gestational age, weight, Apgar, blood tests
Same as current
No Changes Posted
Maternal outcome [ Time Frame: 5 year and 10 year ]
Over all survival, disease free survival
Same as current
Not Provided
Not Provided
 
Breast Cancer During Pregnancy
Observational Study of Breast Cancer Diagnosed During Pregnancy
Patients are managed clinically according to ad hoc standards and scientific knowledge by a multidisciplinary team. Clinical decisions are made after a patient physician discussion. Blood and tissue samples are collected. Diagnostic, obstetric management surgical treatment, systemic treatment, perinatal results and follow up data are collected.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
Blood and tissue samples
Non-Probability Sample
Patients with breast cancer diagnosed during pregnancy
  • Pregnancy
  • Breast Cancer
Not Provided
Subject study
Patients with breast cancer during pregnancy

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
Not Provided
December 2022   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with breast cancer diagnosed during pregnancy

Exclusion Criteria:

  • Patients who refuse informed consent
Sexes Eligible for Study: Female
18 Years to 60 Years   (Adult)
No
Contact: Octavi Cordoba, PhD 34934893184 ocordoba@vhebron.net
Contact: Cristina Saura, MD 34934893105 csaura@vhebron.net
Spain
 
 
NCT02102282
PR(AMI)83/2012
No
Not Provided
Not Provided
Hospital Universitari Vall d'Hebron Research Institute
Hospital Universitari Vall d'Hebron Research Institute
Not Provided
Principal Investigator: Octavi Cordoba, PhD MD Hospital Vall d'Hebron
Hospital Universitari Vall d'Hebron Research Institute
March 2014